Positive screening and carrier results for the England-wide universal newborn sickle cell screening programme by ethnicity and area for 2005-07

被引:42
作者
Streetly, Allison [1 ]
Latinovic, Radoslav [1 ]
Henthorn, Joan [2 ]
机构
[1] Kings Coll London, Sch Med, Div Hlth & Social Care Res, NHS Sickle Cell & Thalassaemia Screening Programm, London SE1 3QD, England
[2] NW London Hosp NHS Trust, Cent Middlesex Hosp, London, England
关键词
IMPLEMENTATION; DISEASE;
D O I
10.1136/jcp.2010.077560
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Aims The overall aim of the new national newborn programme is to identify infants at risk of sickle cell disease to allow early detection and to minimise deaths and complications. Methods Universal screening for sickle cell disease was introduced in England between September 2003 and July 2006. The 13 newborn laboratories each screen between 25 000 and 110 000 babies a year using the existing dried bloodspot cards. The specified conditions to be screened for include sickle cell anaemia (Hb SS), Hb SC disease, Hb S/beta thalassaemia, Hb S/D-Punjab and Hb S/O-Arab. Data are reported on screening results by ethnic group and geographical area. Results The prevalence of screen positive results across England is 1: 2000. There is a 25-fold variation by geographical area. African babies make up 61% of all screen positive results despite representing only 4% of total births. Combined carrier rates vary widely by ethnicity, from 1.85 per 1000 (1: 540) in 'White British' to 145 per 1000 (1: 7) in 'African' babies. Refusal rates for screening show variation by ethnicity. Conclusions These results provide useful information both about the frequency of these conditions and the carrier state and their geographic and ethnic distribution across England. This can be used to refine counselling information and are also useful to target and plan services and public information.
引用
收藏
页码:626 / 629
页数:4
相关论文
共 15 条
[1]  
Human Genetics Commission, 2006, MAK BAB REPR DEC GEN, V11, P485
[2]   Communication of carrier status information following universal newborn screening for sickle cell disorders and cystic fibrosis: qualitative study of experience and practice [J].
Kai, J. ;
Ulph, F. ;
Cullinan, T. ;
Qureshi, N. .
HEALTH TECHNOLOGY ASSESSMENT, 2009, 13 (57) :1-+
[3]  
KAI J, 2009, HEALTH TECHNOL ASSES, V13, pR2
[4]  
KARK JA, 1987, NEW ENGL J MED, V78, P890
[5]  
LIN K, 2007, AHRQ PUBLICATION
[6]  
Lucas SB, 2008, SICKLE CRISIS REPORT
[7]   A brief review on newborn screening methods for hemoglobinopathies and preliminary results selecting beta thalassemia carriers at birth by quantitative estimation of the HbA fraction [J].
Mantikou, Eleni ;
Arkesteijn, Sandra G. ;
Van, Jaqueline M. Beckhoven ;
Kerkhoffs, Jean-Louis ;
Harteveld, Cornelis L. ;
Giordano, Piero Carlo .
CLINICAL BIOCHEMISTRY, 2009, 42 (18) :1780-1785
[8]  
*NHS HAEM SCREEN P, 2001, INT WORKSH REP HAEM
[9]  
*NHS SICKL CELL TH, 2009, HDB LAB
[10]  
NHS Sickle Cell and Thalassaemia Screening Programme, 2006, STAND LINK ANT NEWB